PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.43%
Revenue growth 1.25-1.5x AVGO's 7.53%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
14.79%
Gross profit growth 1.25-1.5x AVGO's 12.07%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
19.89%
EBIT growth 75-90% of AVGO's 23.38%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
19.89%
Operating income growth at 75-90% of AVGO's 23.38%. Bill Ackman would demand a plan to enhance operating leverage.
33.41%
Positive net income growth while AVGO is negative. John Neff might see a big relative performance advantage.
31.43%
Positive EPS growth while AVGO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
36.36%
Positive diluted EPS growth while AVGO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.50%
Slight or no buybacks while AVGO is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
7.80%
Dividend growth above 1.5x AVGO's 0.08%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
17.37%
Similar OCF growth to AVGO's 17.27%. Walter Schloss would assume comparable operations or industry factors.
-13.42%
Negative FCF growth while AVGO is at 18.90%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
121.65%
10Y revenue/share CAGR under 50% of AVGO's 532.60%. Michael Burry would suspect a lasting competitive disadvantage.
169.14%
5Y revenue/share CAGR under 50% of AVGO's 344.03%. Michael Burry would suspect a significant competitive gap or product weakness.
109.03%
3Y revenue/share CAGR 1.25-1.5x AVGO's 98.20%. Bruce Berkowitz might see better product or regional expansions than the competitor.
392.59%
10Y OCF/share CAGR under 50% of AVGO's 1100.58%. Michael Burry would worry about a persistent underperformance in cash creation.
208.14%
Below 50% of AVGO's 648.17%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
175.44%
3Y OCF/share CAGR at 75-90% of AVGO's 203.30%. Bill Ackman would press for improvements in margin or overhead to catch up.
298.40%
Below 50% of AVGO's 3117.50%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
557.65%
5Y net income/share CAGR above 1.5x AVGO's 290.21%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
419.83%
3Y net income/share CAGR above 1.5x AVGO's 74.11%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
161.35%
Below 50% of AVGO's 1675.14%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
58.37%
Below 50% of AVGO's 455.99%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
51.85%
Below 50% of AVGO's 278.82%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
98.71%
Below 50% of AVGO's 663.52%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
76.81%
Below 50% of AVGO's 317.53%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
8.40%
AR growth well above AVGO's 10.47%. Michael Burry fears inflated revenue or higher default risk in the near future.
-7.12%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
14.35%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
17.03%
BV/share growth above 1.5x AVGO's 1.35%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.50%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
9.96%
We increase R&D while AVGO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
3.77%
SG&A growth well above AVGO's 1.28%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.